CD8A and neoplasm: Supporting this idea, engaging MOMP under caspase‐inhibited conditions results in activation of NF‐κB‐mediated upregulation of cytokines and chemokines that promotes activation of antitumorigenic macrophage and cytotoxic CD8+ T cells leading to robust antitumor immune responses culminating in tumor regression [14].